Point72 Asset Management’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,968,293
| Closed | -$3.44M | – | 2713 |
|
|
2025
Q1 | $3.44M | Buy |
1,968,293
+1,073,165
| +120% | +$1.42M | 0.01% | 1073 |
|
|
2024
Q4 | $1.41M | Buy |
895,128
+1,366
| +0.2% | +$2.1K | ﹤0.01% | 1375 |
|
|
2024
Q3 | $1.4M | Buy |
+893,762
| New | +$1.48M | ﹤0.01% | 1307 |
|
|
2021
Q2 | – | Sell |
-321,544
| Closed | -$5.02M | – | 1166 |
|
|
2021
Q1 | $5.02M | Hold |
321,544
| – | – | 0.03% | 567 |
|
|
2020
Q4 | $4.29M | Buy |
+321,544
| New | +$2.36M | 0.02% | 608 |
|
|
2018
Q3 | – | Sell |
-6,150
| Closed | -$486K | – | 1231 |
|
|
2018
Q2 | $486K | Hold |
6,150
| – | – | ﹤0.01% | 871 |
|
|
2018
Q1 | $530K | Sell |
6,150
-3,357
| -35% | -$449K | ﹤0.01% | 849 |
|
|
2017
Q4 | $1.19M | Buy |
+9,507
| New | +$1.2M | 0.01% | 785 |
|